| 1/2 | US=69 / Câncer Quintás-Cardama A, Kantarjian H, Garcia-Manero G, Cortes J. Targeted therapy in myelodysplastic syndrome. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 237-60. ISBN 978-1-60327-423-4. TERAPIA-ALVO; SINDROME MIELODISPLASICA; DECITABINA; A METILACAO DO DNA; 5-AZACITIDINA; LENALIDOMIDA |
| 2/2 | US=35 / Câncer Fandy T, Carraway H, Gore SD. Molecular therapeutics of AML: modulating gene expression as a therapeutic approach in the treatment of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 275-91. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; METILACAO DO DNA; AGENTE DEMETILANTE; 5-AZACITIDINA; INIBIDOR DA HISTONA DEACETILASE; PROMOTOR HIPER-METILACAO; HISTONA ACETILTRANSFERASE; HISTONA METILTRANSFERASE; DECITABINA |